ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 56902 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 56902; 2) Community: the network communities that were significantly associated with the response to NSC 56902; 3) Molecule: the relationships between components within communities and NSC 56902; 4) MDR: the compounds that were significantly associated with the NSC 56902.

NSC Compound Enrichment Correlation
NSC 626030 Naphth[2,3-d]oxazol-4-one, 2-(1,1-dimethylethyl)-9-[(4- fluorophenyl)imino]- 0.00744479268267742 0.26583443
NSC 673803 9-Acridinamine, N-[3-[bis(2-hydroxyethyl)amino]propyl]- 7-methoxy-3-nitro- 0.00744479268267742 0.15928993
NSC 682453 Benzo[1,2-b:5,4-b']dithiophene-4,8-dione, 2-acetyl- 0.00744479268267742 0.43479557
NSC 682756 Spiro[4H-1-benzazepine-4,1'-cyclohexane]-2,5(1H,3H)-dione, 4'-(4-chlorophenyl)-3'-[(4-chlorophenyl)carbonyl]- 4'-hydroxy- 0.00744479268267742 0.19183788
NSC 682994 Benzo[1,2-b:4,5-b']dithiophene-4,8-diol,diester with butanoic acid 0.00744479268267742 0.34982416
NSC 701852 Vorinostat 0.00744479268267742 0.027186119
NSC 606498 Camptothecin Derivative 0.00845932736945076 0.33679754
NSC 639186 Raltitrexed 0.00845932736945076 0.33630776
NSC 652565 Null 0.00845932736945076 0.091276082
NSC 666220 Null 0.00845932736945076 0.012604486
Total:58  Current:10    [First] [Prev] [Next] [Last]